quotes from podcast, http://www.twiv.tv/2010/08/08/twiv-94-xmrv-with-dr-ila-singh/:
"Are these different patients from the science study?"
"Yes, they are completely different patients from the science."
"Finally, an ideal study would use at least one method that has resulted in detection of XMRV in a previous study, preferably using a set of samples that were analyzed in that same previous study and are ‘known’ positives or negatives. In order to avoid any possibility of contamination, it is important that these shared samples not go to any research lab for patient deidentification or aliquoting, but instead go from the phlebotomy lab directly to the researchers who will do the testing."
"It could be for CFS it is a different tissue, right?"
"Yea, it could be the brain for example, who knows right"